scout
Opinion|Videos|August 28, 2024

Indolent Metastatic ccRCC Disease Progression and Guideline Updates

Renal cell carcinoma specialists continue analyzing the case of a 61-year-old patient with indolent metastatic clear cell RCC, evaluating available therapeutic options, discussing disease progression, and addressing recent changes in treatment guidelines.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME